Currently the most advanced independent research into AAGP™ applications is in monoclonal-antibody production and uveitis treatment.
ProtoKinetix anticipates that its future lies as a value-adding compound in two prime areas:
- For challenges in regenerative medicine and the stresses resulting from the harvesting, purification, expansion, cryopreservation, and re-engraftment of cells.
- For the treatment and cures of such inflammation-related conditions as diabetes, arthritis, neural-related diseases.
Accordingly, the Company encourages scientists in both university and private laboratories to view AAGP™ as a spark for new research or as an added component in on-going investigations. It welcomes inquiries and offers AAGP™ in quantities as small as one gram. For ordering information, please click here.
2225 FOLKESTONE WAY
WEST VANCOUVER, BC